Associate Director, US Lung Analytics

Openkrill; United States; Hybrid; USD 177,000 - 221,000; Full time

Job summary

Revolution Medicines is seeking an Associate Director, Lung Analytics to lead analytics for its lung cancer portfolio. Based in Redwood City, CA with flexibility for remote work and travel to the office, you will partner with Commercial, Medical Affairs, Market Access, Clinical Development, and Business Operations to generate actionable insights informing strategy and launch readiness.

You will analyze patient, physician, claims, EMR, and market data, develop KPIs, and guide data strategy while

Qualifications

• Bachelor’s degree required; advanced degree preferred.
• 8+ years in pharmaceutical, biotechnology, healthcare analytics, or management consulting.
• Oncology analytics experience required; lung cancer experience strongly preferred.
• Experience with healthcare claims, EMR, specialty pharmacy, and other patient-level datasets.
• Experience supporting oncology product launches and pre-launch planning.
• Strong analytical, problem-solving, and strategic thinking skills.
• Proven ability to influence cross-functional teams and senior leadership.
• Excellent communication and presentation skills.
• Ability to thrive in a fast-paced, entrepreneurial environment.

Responsibilities

• Lead analytics strategy and execution for Revolution Medicines’ lung cancer portfolio.
• Partner with cross-functional stakeholders to identify key business questions and translate them into analytical plans and actionable recommendations.
• Generate insights from patient-, physician-, claims-, EMR-, and market-level data to inform portfolio strategy, launch planning, and commercial decision-making.
• Develop analyses to understand patient identification, biomarker testing patterns, treatment sequencing, referral pathways, and barriers to adoption.
• Conduct market opportunity assessments, patient journey analyses, and competitive landscape evaluations to support strategic planning.
• Design and execute segmentation, targeting, and opportunity identification analyses to inform customer engagement strategies.
• Monitor evolving standards of care, treatment dynamics, and competitor activity across lung cancer indications.
• Partner with Forecasting, Market Research, and Competitive Intelligence colleagues to develop an integrated view of market performance and future growth opportunities.
• Lead development of key performance metrics, dashboards, and launch readiness assessments.
• Inform data acquisition and data strategy decisions to ensure availability of fit-for-purpose oncology data assets.
• Manage external analytics vendors and ensure timely delivery of high-quality analyses.
• Communicate insights and strategic implications to senior leadership through clear, concise, and compelling recommendations.
• Represent Revolution Medicines’ values in all internal and external interactions.

Skills

Oncology analytics

Claims data analysis

EMR data analytics

Strategic thinking

Cross-functional leadership

Communication skills

Presentation skills

Forecasting / AI/ML applications

Education

Bachelor’s degree

MBA / MPH / MS / PhD preferred

Job description

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Opportunity:

Reporting to the Executive Director, Lung Analytics & Insights, the Associate Director, Lung Analytics will serve as the analytics lead for Revolution Medicines’ lung cancer portfolio.

This role will partner closely with Commercial, Medical Affairs, Market Access, Clinical Development, and Business Operations to generate actionable insights that inform portfolio strategy, launch readiness, commercialization planning, and business performance.

The role requires a strong understanding of the lung cancer treatment landscape, patient journey, biomarker-driven markets, and oncology data assets.

This position is based at our Redwood City, CA headquarters, with flexibility for remote candidates willing to travel regularly to the office.

Key Responsibilities:

• Lead analytics strategy and execution for Revolution Medicines’ lung cancer portfolio.
• Partner with cross-functional stakeholders to identify key business questions and translate them into analytical plans and actionable recommendations.
• Generate insights from patient-, physician-, claims-, EMR-, and market-level data to inform portfolio strategy, launch planning, and commercial decision-making.
• Develop analyses to understand patient identification, biomarker testing patterns, treatment sequencing, referral pathways, and barriers to adoption.
• Conduct market opportunity assessments, patient journey analyses, and competitive landscape evaluations to support strategic planning.
• Design and execute segmentation, targeting, and opportunity identification analyses to inform customer engagement strategies.
• Monitor evolving standards of care, treatment dynamics, and competitor activity across lung cancer indications.
• Partner with Forecasting, Market Research, and Competitive Intelligence colleagues to develop an integrated view of market performance and future growth opportunities.
• Lead development of key performance metrics, dashboards, and launch readiness assessments.
• Inform data acquisition and data strategy decisions to ensure availability of fit-for-purpose oncology data assets.
• Manage external analytics vendors and ensure timely delivery of high-quality analyses.
• Communicate insights and strategic implications to senior leadership through clear, concise, and compelling recommendations.
• Represent Revolution Medicines’ values in all internal and external interactions.

Required Skills, Experience and Education:

• Bachelor’s degree required; advanced degree preferred.
• 8+ years of experience in pharmaceutical, biotechnology, healthcare analytics, or management consulting.
• Oncology analytics experience required; lung cancer experience strongly preferred.
• Demonstrated expertise working with healthcare claims, EMR, specialty pharmacy, and other patient-level datasets.
• Experience supporting oncology product launches and pre-launch planning.
• Strong analytical, problem-solving, and strategic thinking skills.
• Proven ability to influence cross-functional teams and senior leadership.
• Excellent communication and presentation skills.
• Ability to thrive in a fast-paced, entrepreneurial environment.

Preferred Skills:

• MBA, MPH, MS, or PhD.
• Deep understanding of NSCLC and biomarker-driven oncology markets.
• Experience supporting targeted oncology therapies.
• Experience with advanced analytics, predictive modeling, AI/ML applications, or commercial forecasting.
• Prior experience in a growth-stage biotechnology company.

Base Pay Salary Range$177,000-$221,000 USD

Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.

Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [e-mail].